Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Protocol for outcome reporting and follow-up in the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest trial (TTM2)

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Age-specific trends in incidence and survival of out-of-hospital cardiac arrest from presumed cardiac cause in Denmark 2002-2014

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Regional variation in out-of-hospital cardiac arrest: incidence and survival - a nationwide study of regions in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Socioeconomic differences in coronary procedures and survival after out-of-hospital cardiac arrest: A nationwide Danish study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Gisela Lilja
  • Niklas Nielsen
  • Susann Ullén
  • Erik Blennow Nordstrom
  • Josef Dankiewicz
  • Hans Friberg
  • Katarina Heimburg
  • Janus Christian Jakobsen
  • Helena Levin
  • Clifton Callaway
  • Alain Cariou
  • Glenn M Eastwood
  • Raimund Helbok
  • Jan Hovdenes
  • Hans Kirkegaard
  • Christoph Leithner
  • Matt P G Morgan
  • Per Nordberg
  • Mauro Oddo
  • Paolo Pelosi
  • Christian Rylander
  • Manoj Saxena
  • Fabio Silvio Taccone
  • Michal Siranec
  • Matthew P Wise
  • Paul J Young
  • Tobias Cronberg
View graph of relations

AIMS: The TTM2-trial is a multi-centre randomised clinical trial where targeted temperature management (TTM) at 33 °C will be compared with normothermia and early treatment of fever (≥37.8°C) after Out-of-Hospital Cardiac Arrest (OHCA). This paper presents the design and rationale of the TTM2-trial follow-up, where information on secondary and exploratory outcomes will be collected. We also present the explorative outcome analyses which will focus on neurocognitive function and societal participation in OHCA-survivors.

METHODS: Blinded outcome-assessors will perform follow-up at 30-days after the OHCA with a telephone interview, including the modified Rankin Scale (mRS) and the Glasgow Outcome Scale Extended (GOSE). Face-to-face meetings will be performed at 6 and 24-months, and include reports on outcome from several sources of information: clinician-reported: mRS, GOSE; patient-reported: EuroQol-5 Dimensions-5 Level responses version (EQ-5D-5 L), Life satisfaction, Two Simple Questions; observer-reported: Informant Questionnaire on Cognitive Decline in the Elderly-Cardiac Arrest version (IQCODE-CA) and neurocognitive performance measures: Montreal Cognitive Assessment, (MoCA), Symbol Digit Modalities Test (SDMT). Exploratory analyses will be performed with an emphasis on brain injury in the survivors, where the two intervention groups will be compared for potential differences in neuro-cognitive function (MoCA, SDMT) and societal participation (GOSE). Strategies to increase inter-rater reliability and decrease missing data are described.

DISCUSSION: The TTM2-trial follow-up is a pragmatic yet detailed pre-planned and standardised assessment of patient's outcome designed to ensure data-quality, decrease missing data and provide optimal conditions to investigate clinically relevant effects of TTM, including OHCA-survivors' neurocognitive function and societal participation.

Original languageEnglish
JournalResuscitation
Volume150
Pages (from-to)104-112
Number of pages9
ISSN0300-9572
DOIs
Publication statusPublished - May 2020

Bibliographical note

Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

    Research areas

  • Cardiac arrest, Cognitive function, Patient Reported Outcome Measures, Quality of life, Treatment outcome

ID: 59623247